The HIV Virologic Outcomes of Different Interventions Among Treatment-Experienced Patients With 2 Consecutive Detectable Low-Level Viremia
- 1 January 2011
- journal article
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 10 (1), 54-56
- https://doi.org/10.1177/1545109710385122
Abstract
Background: Approaches to treatment-experienced HIV-infected patients with persistent low-level viremia are limited by current commercial resistance genotyping assays when the viral load (VL) isKeywords
This publication has 9 references indexed in Scilit:
- Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral TherapyClinical Infectious Diseases, 2010
- Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurementsAIDS, 2009
- Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapyHIV Medicine, 2006
- Utility of Interrupting Antiretroviral Treatment Before HIV Drug Resistance Testing in Patients With Persistently Detectable Low-Level ViremiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAARTJAMA, 2005
- Genotypic Resistance in HIV‐1–Infected Patients with Persistently Detectable Low‐Level Viremia while Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2004
- Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment responseAIDS, 2003
- Prevalence and Predictive Value of Intermittent Viremia With Combination HIV TherapyJAMA, 2001
- HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination TherapyJAMA, 2001